Carboplatin dosing in children: calculation by different formulae

Onkologie. 2011;34(1-2):16-22. doi: 10.1159/000323369. Epub 2011 Jan 17.

Abstract

Background: Carboplatin dosing in children is based on renal function and there exists a wealth of formulae available for calculating the body surface area (BSA), the glomerular filtration rate (GFR), and the carboplatin dose.

Patients and methods: A fictitious group of children with different ages and body builds was 'constructed'. For comparison of formulae, bias and precision were assessed.

Results: BSA calculations according to DuBois-DuBois, Gehan-George, Mosteller, and Boyd showed good agreement. GFR calculations according to the weight-based Cole formula and the Léger formula gave comparable results. Regarding GFR in young children, the weight-and creatinine-based Cole and the Schwartz formula showed clear differences. Again, carboplatin dose calculations according to Marina, Newell, and Chatelut are comparable. Moreover, the precision of the creatinine measurement has a clear influence on the result of the dose calculation.

Conclusions: The choice of the GFR formula is more important for the carboplatin dose calculation compared to the BSA or dose equation. GFR calculations in children show marked, age-dependent variations. A sequence of multiple calculation steps (especially for the Schwartz and Marina formulae) may lead to considerable uncertainty and proneness to error in the clinical routine. In high-risk patients, GFR should be measured precisely and complemented by therapeutic drug monitoring.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacokinetics
  • Body Weight
  • Carboplatin / administration & dosage*
  • Carboplatin / pharmacokinetics*
  • Computer Simulation
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Computer-Assisted / methods*
  • Glomerular Filtration Rate
  • Humans
  • Kidney / drug effects
  • Kidney / metabolism*
  • Metabolic Clearance Rate
  • Models, Biological*
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism*
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Antineoplastic Agents
  • Carboplatin